KPRX
Price
$3.09
Change
-$0.10 (-3.13%)
Updated
Jun 5 closing price
Capitalization
9.41M
PVLA
Price
$23.49
Change
-$0.32 (-1.34%)
Updated
Jun 5 closing price
Capitalization
259.7M
Interact to see
Advertisement

KPRX vs PVLA

Header iconKPRX vs PVLA Comparison
Open Charts KPRX vs PVLABanner chart's image
Kiora Pharmaceuticals
Price$3.09
Change-$0.10 (-3.13%)
Volume$355.75K
Capitalization9.41M
Palvella Therapeutics
Price$23.49
Change-$0.32 (-1.34%)
Volume$48.2K
Capitalization259.7M
KPRX vs PVLA Comparison Chart
Loading...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PVLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KPRX vs. PVLA commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KPRX is a Hold and PVLA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (KPRX: $3.09 vs. PVLA: $23.49)
Brand notoriety: KPRX and PVLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KPRX: 61% vs. PVLA: 62%
Market capitalization -- KPRX: $9.41M vs. PVLA: $259.7M
KPRX [@Biotechnology] is valued at $9.41M. PVLA’s [@Biotechnology] market capitalization is $259.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KPRX’s FA Score shows that 3 FA rating(s) are green whilePVLA’s FA Score has 1 green FA rating(s).

  • KPRX’s FA Score: 3 green, 2 red.
  • PVLA’s FA Score: 1 green, 4 red.
According to our system of comparison, KPRX is a better buy in the long-term than PVLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KPRX’s TA Score shows that 7 TA indicator(s) are bullish while PVLA’s TA Score has 3 bullish TA indicator(s).

  • KPRX’s TA Score: 7 bullish, 3 bearish.
  • PVLA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, KPRX is a better buy in the short-term than PVLA.

Price Growth

KPRX (@Biotechnology) experienced а +3.00% price change this week, while PVLA (@Biotechnology) price change was -5.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

KPRX is expected to report earnings on May 09, 2025.

PVLA is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PVLA($260M) has a higher market cap than KPRX($9.41M). PVLA has higher P/E ratio than KPRX: PVLA (14.22) vs KPRX (3.67). PVLA YTD gains are higher at: 95.750 vs. KPRX (-6.364).
KPRXPVLAKPRX / PVLA
Capitalization9.41M260M4%
EBITDA2.39MN/A-
Gain YTD-6.36495.750-7%
P/E Ratio3.6714.2226%
Revenue16MN/A-
Total Cash29MN/A-
Total Debt72.6KN/A-
FUNDAMENTALS RATINGS
KPRX vs PVLA: Fundamental Ratings
KPRX
PVLA
OUTLOOK RATING
1..100
9410
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
32100
PRICE GROWTH RATING
1..100
7639
P/E GROWTH RATING
1..100
112
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KPRX's Valuation (23) in the Pharmaceuticals Other industry is somewhat better than the same rating for PVLA (61) in the null industry. This means that KPRX’s stock grew somewhat faster than PVLA’s over the last 12 months.

KPRX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as PVLA (100) in the null industry. This means that KPRX’s stock grew similarly to PVLA’s over the last 12 months.

KPRX's SMR Rating (32) in the Pharmaceuticals Other industry is significantly better than the same rating for PVLA (100) in the null industry. This means that KPRX’s stock grew significantly faster than PVLA’s over the last 12 months.

PVLA's Price Growth Rating (39) in the null industry is somewhat better than the same rating for KPRX (76) in the Pharmaceuticals Other industry. This means that PVLA’s stock grew somewhat faster than KPRX’s over the last 12 months.

KPRX's P/E Growth Rating (1) in the Pharmaceuticals Other industry is in the same range as PVLA (12) in the null industry. This means that KPRX’s stock grew similarly to PVLA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KPRXPVLA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 21 days ago
80%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PVLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRCY52.020.44
+0.85%
Mercury Systems
H129.96-1.00
-0.76%
Hyatt Hotels Corp
LFCR6.76-0.11
-1.67%
Lifecore Biomedical
JVA4.18-0.10
-2.22%
Coffee Holding Co
GYRE7.94-0.64
-7.46%
Gyre Therapeutics

KPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KPRX has been loosely correlated with OVID. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if KPRX jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPRX
1D Price
Change %
KPRX100%
-3.13%
OVID - KPRX
36%
Loosely correlated
+0.48%
SYRE - KPRX
33%
Loosely correlated
+0.54%
PRME - KPRX
31%
Poorly correlated
+3.79%
APRE - KPRX
31%
Poorly correlated
-6.70%
AKTX - KPRX
30%
Poorly correlated
-5.03%
More

PVLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PVLA has been loosely correlated with DRMA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PVLA jumps, then DRMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVLA
1D Price
Change %
PVLA100%
-1.34%
DRMA - PVLA
36%
Loosely correlated
-0.56%
DSGN - PVLA
30%
Poorly correlated
-2.44%
KPRX - PVLA
26%
Poorly correlated
-3.13%
IKNA - PVLA
25%
Poorly correlated
-2.61%
PTGX - PVLA
25%
Poorly correlated
+4.44%
More